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Objectives: Diabetes Mellitus is best managed through a combination of HbA1c 
testing, self-testing of blood glucose, and close interactions with HCPs. It has been 
previously shown that Italian diabetes patients have a very low rate of adherence 
to appropriate care, compared to those in other EU countries. In this study, we 
examined Italian diabetes patient preferences related to education and moni-
toring compared to patients in other EU5 countries. MethOds: A total of 3,013 
diabetes patients in the EU5 were sampled. Questions focused on demographic, 
lifestyle, treatment, access to information, and socioeconomic status. Data were 
compared across countries and reported behaviors compared to current patient 
treatment guidelines. Results: Despite guidelines stating that all patients must 
receive HbA1c testing twice per year, 42.5% of Italian patients reported receiving 
an HbA1c test in the past 12 months compared to 70.5% in other EU5 countries. 
Instead, these patients are favoring blood glucose self-monitoring, which has 
been previously shown to be an insufficient substitute for HbA1c testing. Italian 
patients also claimed that they do not want their doctor or nurse managing their 
diabetes more so than patients in any other tested country. Italians get diabetes 
information from Newspapers/Magazines, Internet, TV/Radio, Relatives/Friends 
more than other Europeans (37% v 34%; 33% v 28%; 30% v 26%; 25% v 21% respec-
tively). cOnclusiOns: While many Italian diabetes patients are reporting low 
adherence to guideline driven testing and preferences for managing their own 
diabetes without intervention from their HCP, change is needed. This represents a 
major opportunity for more targeted Italian patient management solutions built on 
Italian patient preferences and recognition of necessary change drivers to realize 
more cost-effective care. This study demonstrates how local patient preferences can 
impact outcomes, and therefore must be built into chronic disease management 
solutions for meaningful change to occur.
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Objectives: Type 1 diabetes is often associated with complications that may have 
a pronounced impact on health-related quality of life (HRQoL). The aim was to 
conduct a systematic literature review to identify studies conducted exclusively in 
type 1 diabetes populations reporting utility values for diabetes-related complica-
tions. MethOds: Literature searches of the PubMed, EMBASE and Cochrane Library 
databases were performed in line with PRISMA guidance; searches used Medical 
Subject Heading (MeSH) terms supplemented with free-text terms. For inclusion, 
studies were required to be conducted exclusively in adults with type 1 diabe-
tes, published in English from 2000 onwards, and report utility values determined 
using either direct or indirect assessment methods. Results: Searches identified 
a total of 20 studies reporting utility values for complications in type 1 diabetes, 
of which a total of 9 studies used the EQ-5D, 2 used the 15D, 3 used the Quality of 
Well-Being questionnaire and 5 used direct methods including time trade-off and 
standard gamble. For patients with no complications reported utility values ranged 
from 0.90–0.98. Complications including stroke (reported disutility range −0.105 to 
−0.291), neuropathy (range −0.055 to −0.358) and blindness (range −0.132 to −0.208) 
were associated with among the largest decrements in utility values. Poor glycemic 
control was also found to be associated with lower utility values. Data gaps in the 
literature exist, e.g. EQ-5D utility values for amputation and end-stage renal dis-
ease are lacking. cOnclusiOns: Differences between type 1 and type 2 diabetes 
populations mean for economic evaluation it is preferable to obtain utility values 
from exclusively type 1 diabetes populations. In type 1 diabetes the presence of 
complications has a significant detrimental impact on HRQoL, but the magnitude of 
the impact depends on the choice of HRQoL instrument. This will have implications 
on cost-effectiveness models of type 1 diabetes.
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Objectives: Diabetes mellitus (DM) is a chronic disease and patients have higher 
objective healthcare needs compared to the general population. The healthcare sup-
portive services help the good control of diabetes, avoiding or delaying the disease 
complications and assuring the patient’s adherence to the treatment. The objec-
tive of this study is to assess the patients reported needs of additional healthcare, 
psychological or family supportive care and the specific gaps in the healthcare 
management of the disease in Bulgaria. MethOds: A total of 245 adults diagnosed 
with DM type 1 and 2 were recruited and completed a self-report questionnaires at 
three hospitals - in the capital and in two main other cities. Of them 203 were com-
plete and eligible for analysis. Unmet needs were assessed using 15-item question-
naire. The data were examined using descriptive statistics. Results: Unmet needs 
were most commonly reported in the aspects of healthcare services’ domains. The 
three most frequently endorsed items of “moderate to severe” unmet needs were: 
additional information about the disease from the endocrinologist (65.35%), struc-
tured information about the disease and its treatment given in the hospital from 
the doctor (68.81%) and needs of special foot care medical offices for patients with 
diabetic neuropathy (68.81%). Approximately 76% of the patients reported having 
unmet needs of more free test-strips for self-monitoring blood glucose, medicinal 
products and special healthcare services for diabetics. 73 patients (36.14%) reported 
high importance of the active participation of the pharmacist in community phar-
macy in recognizing of probable and current drug related problems. 101 of the 
patients (50%) reported need of higher psychological support from their relatives 
18 had HbA1c> 8.0%. A total of 42% (126/302) used basal-insulin only, 29% (88/302) 
bolus-insulin only, 22% (66/302) basal-bolus, 5% (16/302) premixed and 2% (6/302) 
other combinations. Of all respondents, 81% (246/302) had previously experienced 
non-severe (self-managed) hypoglycaemia (79% (59/75) in those with HbA1c> 8%), 
with 11% (28/246) reporting 3 events per-week, 33% (80/246) once-a-week, and 29% 
(72/246) once-a-month. 30% (92/302) had previously experienced severe hypoglycae-
mia requiring help from others, with half (46/92) reporting 1-3 such events during 
past year. 73% (221/302) of respondents tested blood glucose 2-5 times-daily. Of 
192 respondents using basal insulin, 134 (70%) injected ≤ 1 time-a-day, whilst 30% 
(58/192) injected ≥ 2 times-daily. When asked about intensifying by adding bolus-
insulin or switching to premix, 58% (73/126) of basal-only patients would be hesitant. 
Most frequent reason for hesitation was increased number of daily injections (44%, 
32/73), as well as pain/discomfort of injections and risk of weight gain (both 23%; 
17/73), hypoglycaemia risk (22%; 16/73), difficulty calculating bolus dose with food 
(21%; 15/73). cOnclusiOns: Number and timing of injections, dose calculation, 
risk of hypoglycaemia and weight gain are barriers to insulin intensification among 
T2DM patients on basal insulin in Italy. Therapies addressing these may help to 
achieve treatment goals.
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Objectives: Diabetes mellitus is a serious health problem. Medication adherence 
is a key determinant of therapeutic success in patients with diabetes mellitus. 
The purpose of this study was to assess medication adherence and its potential 
association with diabetes related knowledge in patients with type 2 diabetes mel-
litus. MethOds: This study was carried out at the outpatient clinics of a public 
sector teaching hospital in Sargodha, Pakistan. Besides demographic and dis-
ease-related questions, previously validated questionnaires, Morisky Medication 
Adherence Scale and Michigan diabetes knowledge test was used to assess the 
medication adherence and diabetes related knowledge, respectively. Descriptive 
statistics were used to determine the demographic and disease characteristics 
of the patients while Spearman rank correlation was employed to measure the 
association between medication adherence and knowledge. Results: Three hun-
dred and ninety two patients were interviewed. Out of 392 patients, 245 (62.5%) 
of the patients had average knowledge about diabetes while 282 (71.9 %) were 
categorized as poor adherent. Only 13 patients (3.3 %) were considered as good 
adherent in the study. The correlation coefficient between total scores of knowl-
edge and total medication adherence score was 0.036 (p< 0.05), indicating a weak 
correlation between knowledge scores and adherence level. cOnclusiOns: 
Knowledge of diabetes mellitus among these patients was average; however, 
adherence to drug therapy was also poor. Patients’ knowledge about diabetes had 
positive association with medication adherence. Improving diabetes knowledge 
of people can result in better adherence, which may result in better control of 
diabetes.
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Objectives: Patient adherence with a therapeutic regimen predicts success-
ful treatment and reduces the severity of negative complications. The objective 
of this study was to explore the relationship between Health-Related Quality of 
Life (HRQoL) and treatment adherence among type 2 diabetes mellitus patients 
in Sargodha, Pakistan. MethOds: The study was designed as a cross-sectional 
descriptive survey. Type 2 diabetic patients attending a tertiary care institute in 
Sargodha, Pakistan were targeted for the study. The Urdu version of the Morisky 
Medication Adherence Scale (MMAS-Urdu) and EuroQol Quality of Life Scale (EQ-
5D) was used to assess medication adherence and HRQoL, respectively. Descriptive 
statistics were used for the elaboration of socio-demographic characteristics. The 
Spearman’s Rho correlation test was used to measure the association between 
medication adherence and HRQoL. P < 0.05 was taken as significant. Results: 
Three hundred and ninety two patients were approached for the study. The cohort 
was dominated by males (n= 222, 56.60 %) with 5.58± 4.09 years of history of type 2 
diabetes mellitus. The majority of respondents (n= 137, 34.90 %) was categorized in 
age group of 51 to 60 years with mean age of 50.77 ± 9.671 years. The present study 
highlighted that individuals with type 2 diabetes mellitus had decreased HRQoL 
(0.4715 ± 0.3360) and poor medication adherence (4.44± 1.8). Significant, yet weak 
positive correlations were observed between medication adherence and HRQoL (r= 
0.217 and 0.136 for EQ-5D and EQ-VAS respectively). cOnclusiOns: Although the 
association between adherence to therapeutic regimen and HRQoL in the present 
study cohort was significant, it was rated as weak, hence failed in producing an 
overall impression on quality of life. The study, therefore, highlights the need to 
identify other individual factors affecting HRQoL among type 2 diabetes mellitus 
patients in Pakistan.
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